Article

Talia Technology chief steps down after 3 years

Tampa, FL-Ted Newill, the president of Talia Technology Inc., is stepping down after 3 years at the helm.

Tampa, FL-Ted Newill, the president of Talia Technology Inc., is stepping down after 3 years at the helm.

Newill said he is leaving the company, effective July 30, for personal reasons. He led the 2004 Year of the Customer campaign and played a major role in the reorganization of the U.S. office. Talia Technology Inc. is the U.S. subsidiary of Talia Technology Ltd., which develops and sells the RTA for diagnosing glaucoma, diabetic retinopathy, age-related macular degeneration, and more.

While the company searches for a new president, Chief Executive Officer Dan Moran will manage operations.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.